Rob Goodman

Rob Goodman, MB BChir, MBA is the Chair of the Department of Radiology & Biomedical Imaging at Yale School of Medicine, Chief of Radiology at Yale New Haven Hospital and Radiologist-in-Chief at Yale New Haven Health System.

Dr. Goodman joined Yale in 2004 from the John Radcliffe Hospital in Oxford, UK, where he was lead clinician for its radiology department. He obtained his medical degree from Cambridge University in 1988 and an MBA in Healthcare from Yale in 2017. Upon completing his residency at the Central Oxford Hospitals in the UK, he did a fellowship in pediatric radiology at The Hospital for Sick Children in Toronto.

After his relocation from Europe to the United States, he was struck by the marked differences in radiation awareness between the two countries, which is particularly relevant in pediatric radiology due to children’s susceptibility to the effects of radiation. He subsequently played a major role in the movement to reduce radiation exposure from CT scans in children, as well as adults. As a way to reduce radiation exposure, his clinical interests also included improved utilization of ultrasound in pediatric imaging. He has published and lectured on these topics nationally and is the Pediatric Community of Practice President for the American Institute for Ultrasound in Medicine, and sits on its Board of Governors. He has been involved in developing national consensus guidelines for such topics as neonatal echoencephalography, pediatric spinal ultrasound, hip ultrasound, and imaging in pregnant patients.

During his tenure at Yale, Dr. Goodman has overseen the expansion of pediatric radiology services, spearheaded the installation of a dedicated pediatric MRI scanner at Yale New Haven Children’s Hospital, implemented a critical test result reporting system, and identified mechanisms to improve the radiology peer review process. He recently helped execute an imaging industry relationship with Siemens Healthcare for Yale New Haven Health System.

As Chair, Dr. Goodman is building upon the department’s clinical strengths and world-class research taking place in such areas as novel MR pulse sequences, functional MRI, MR spectroscopy, novel PET tracers, and advanced image processing. By including industry partners, he is eager to expand its translational research program to help convert basic science discoveries into clinical applications that improve patient care.